Incomplete protective effects of minocycline on traumatic brain injury in rats and mice

Wen-wen SHENG; Wei-ping ZHANG; Meng-ling WANG; Shi-hong ZHANG; Hua HU; Sheng-li CHU; Yu ZHOU; San-hua FANG; Guo-liang YU; Xiao-dong QIAN; Ke-da CHEN; Hui-min XU; Lu-ying LIU; Lei ZHANG; Er-qing WEI.
Journal of Zhejiang University. Medical sciences ; (6): 411-418, 2006.
Artículo en Zh | WPRIM | ID: wpr-332133

Documentos relacionados

  1. Safety evaluation and pharmacodynamics of minocycline hydrochloride eye drops.
  2. Minocycline alleviates depression-like symptoms by rescuing decrease in neurogenesis in dorsal hippocampus via blocking microglia activation/phagocytosis.
  3. Minocycline Activates the Nucleus of the Solitary Tract-Associated Network to Alleviate Lipopolysaccharide-Induced Neuroinflammation.
  4. Minocycline improves cognition and molecular measures of inflammation and neurodegeneration following repetitive mTBI.
  5. Porcine Pluripotent Stem Cells Established from LCDM Medium with Characteristics Differ from Human and Mouse Extended Pluripotent Stem Cells.
  6. Update on minocycline in vitro activity against odontogenic bacteria.
  7. Tolerance-inducing effect and properties of innate immune stimulation on chronic stress-induced behavioral abnormalities in mice.
  8. Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints.
  9. Structural Preservation Does Not Ensure Function at Sensory Ia-Motoneuron Synapses following Peripheral Nerve Injury and Repair.
  10. Indicaciones y Complicaciones del Implante de Marcapasos Endocárdico Percutáneo Definitivo en Paciente del Hospital Militar Central de El Salvador en el Periodo de Enero 2018 a Diciembre 2021